Cargando…
The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues
Widespread diagnostic and serological (antibody) testing is one key to mitigating the COVID-19 pandemic. While at first, the majority of COVID-19 diagnostic testing in the USA took place in healthcare settings, quickly a direct-to-consumer (DTC) testing market also emerged. In these DTC provision mo...
Autores principales: | Kalokairinou, Louiza, Zettler, Patricia J, Nagappan, Ashwini, Kyweluk, Moira A, Wexler, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543538/ https://www.ncbi.nlm.nih.gov/pubmed/33569177 http://dx.doi.org/10.1093/jlb/lsaa069 |
Ejemplares similares
-
Ethical Issues Associated With Direct-to-Consumer Genetic Testing
por: Panacer, Kirpal S
Publicado: (2023) -
The ethics and regulation of direct-to-consumer genetic testing
por: Boddington, Paula
Publicado: (2009) -
Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape
por: Kalokairinou, L., et al.
Publicado: (2017) -
Pregnant at the start of the pandemic: a content analysis of COVID-19-related posts on online pregnancy discussion boards
por: Choi, Rebekah, et al.
Publicado: (2022) -
Ethical issues in consumer genome sequencing: Use of consumers' samples and data
por: Niemiec, Emilia, et al.
Publicado: (2016)